Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Galapagos Sells CRO To Selvita For €31.2m

Fidelta No Longer Fits Strategy

Nov 24 2020

• By Kevin Grogan

Zagreb — Zagreb is home to Fidelta • Source: Shutterstock

Related Content

Gilead’s RA Hopeful Filgotinib Hit By Complete Response Letter

Aug 19 2020

Poland’s Ryvu To Feed Galapagos’ R&D Effort

Apr 16 2020

Shaking Off US Rebuff, Gilead And Galapagos Get Filgotinib Green Lights In EU And Japan

Sep 28 2020

Galapagos Knocked By Knee Osteoarthritis Fail

Oct 16 2020

Related Companies

Galapagos NV

Ryvu Therapeutics

Molecure

Gilead Sciences, Inc.

Eisai Co., Ltd.

Additional Topics

M & A Companies Strategy Commercial Deals BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window